📣 VC round data is live. Check it out!

Krakchemia Valuation Multiples

Discover revenue and EBITDA valuation multiples for Krakchemia and similar public comparables like Recyctec Holding, Tekchem, Polymer Factory Sweden, Meranol and more.

Krakchemia Overview

About Krakchemia

Krakchemia SA specializes in the wholesale of plastic granulates, laboratory chemicals, and chemical raw materials. The company's main activity is wholesale trade in chemical products, mainly plastic granulates, packaging foils, plastics, reagents, and chemical raw materials. It sells commercial goods on the domestic market and in small quantities abroad, with operations covering Poland, Slovakia, the Czech Republic, Germany, and other foreign markets.


Founded

1945

HQ

Poland

Employees

N/A

Sectors

Financials (FY)

Revenue: $7M
EBITDA: ($1M)

EV

$822K

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Krakchemia Financials

Krakchemia reported last fiscal year revenue of $7M and negative EBITDA of ($1M).

In the same fiscal year, Krakchemia generated $845K in gross profit, ($1M) in EBITDA losses, and had net loss of ($3M).


Krakchemia P&L

In the most recent fiscal year, Krakchemia reported revenue of $7M and EBITDA of ($1M).

Krakchemia is unprofitable as of last fiscal year, with gross margin of 12%, EBITDA margin of (21%), and net margin of (48%).

See analyst estimates for Krakchemia
Last FY202320242025202620272028
Revenue$7M$22M$12M$7M
Gross Profit$845K$2M$2M$845K
Gross Margin12%9%13%12%
EBITDA($1M)($13M)($2M)($1M)
EBITDA Margin(21%)(60%)(13%)(21%)
EBIT Margin(27%)(57%)(13%)(27%)
Net Profit($3M)($19M)($4M)($3M)
Net Margin(48%)(85%)(30%)(48%)

Financial data powered by Morningstar, Inc.

Krakchemia Stock Performance

Krakchemia has current market cap of $781K, and enterprise value of $822K.

Market Cap Evolution


Krakchemia's stock price is $0.09.

Krakchemia share price decreased by 5.8% in the last 30 days, and by 68.0% in the last year.

Krakchemia has an EPS (earnings per share) of $-0.37.

See more trading valuation data for Krakchemia
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$822K$781K-0.7%-5.8%-19.4%-68.0%$-0.37

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Krakchemia Valuation Multiples

Krakchemia trades at 0.1x EV/Revenue multiple, and (0.6x) EV/EBITDA.

See NTM and 2027E valuation multiples for Krakchemia

Krakchemia Financial Valuation Multiples

As of May 22, 2026, Krakchemia has market cap of $781K and EV of $822K.

Krakchemia has a P/E ratio of (0.2x).

Last FY202320242025202620272028
EV/Revenue0.1x0.0x0.1x0.1x
EV/EBITDA(0.6x)(0.1x)(0.5x)(0.6x)
EV/EBIT(0.4x)(0.1x)(0.5x)(0.4x)
EV/Gross Profit1.0x0.4x0.5x1.0x
P/E(0.2x)(0.0x)(0.2x)(0.2x)
EV/FCF(2.1x)3.7x(11.3x)(2.1x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Krakchemia Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Krakchemia Margins & Growth Rates

In the most recent fiscal year, Krakchemia reported gross margin of 12%, EBITDA margin of (21%), and net margin of (48%).

See estimated margins and future growth rates for Krakchemia

Krakchemia Margins

Last FY20242025202720282029
Gross Margin12%13%12%
EBITDA Margin(21%)(13%)(21%)
EBIT Margin(27%)(13%)(27%)
Net Margin(48%)(30%)(48%)
FCF Margin(6%)(1%)(6%)

Krakchemia Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(44%)(44%)
Gross Profit Growth(19%)(46%)
EBITDA Growth(88%)(9%)
EBIT Growth(87%)12%
Net Profit Growth(80%)(10%)
FCF Growth(133%)438%

Data powered by FactSet, Inc. and Morningstar, Inc.

Krakchemia Operational KPIs

Access forward-looking KPIs for Krakchemia
Last FY202320242025202620272028
S&M Expenses to Revenue20%8%12%20%
G&A Expenses to Revenue21%7%13%21%
Opex to Revenue39%66%26%39%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Krakchemia Competitors

Krakchemia competitors include Recyctec Holding, Tekchem, Polymer Factory Sweden, Meranol, Black Point, Global Bioenergies, SZAR, Biofrigas Sweden, Lima Caucho and Nattaro Labs.

Most Krakchemia public comparables operate across Chemicals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Recyctec Holding0.6x(1.6x)
Tekchem
Polymer Factory Sweden3.3x(2.6x)
Meranol0.0x0.1x
Black Point0.2x(27.5x)
Global Bioenergies
SZAR0.5x(4.5x)
Biofrigas Sweden58.7x(1.5x)

This data is available for Pro users. Sign up to see all Krakchemia competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Krakchemia

When was Krakchemia founded?Krakchemia was founded in 1945.
Where is Krakchemia headquartered?Krakchemia is headquartered in Poland.
Is Krakchemia publicly listed?Yes, Krakchemia is a public company listed on Warsaw Stock Exchange.
What is the stock symbol of Krakchemia?Krakchemia trades under KCH ticker.
When did Krakchemia go public?Krakchemia went public in 2007.
Who are competitors of Krakchemia?Krakchemia main competitors include Recyctec Holding, Tekchem, Polymer Factory Sweden, Meranol, Black Point, Global Bioenergies, SZAR, Biofrigas Sweden, Lima Caucho, Nattaro Labs.
What is the current market cap of Krakchemia?Krakchemia's current market cap is $781K.
What is the current revenue of Krakchemia?Krakchemia's last fiscal year revenue is $7M.
What is the current EV/Revenue multiple of Krakchemia?Current revenue multiple of Krakchemia is 0.1x.
Is Krakchemia profitable?No, Krakchemia is not profitable.
How many companies Krakchemia has acquired to date?Krakchemia hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Krakchemia has invested to date?Krakchemia hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Krakchemia

Lists including Krakchemia

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial